Vanguard Group Inc Nurix Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,011,814 shares of NRIX stock, worth $86.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,011,814
Previous 3,625,014 10.67%
Holding current value
$86.2 Million
Previous $75.7 Million 19.05%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$18.93 - $25.69 $7.32 Million - $9.94 Million
386,800 Added 10.67%
4,011,814 $90.1 Million
Q2 2024

Aug 13, 2024
BUY
$12.02 - $21.3 $12.5 Million - $22.2 Million
1,040,714 Added 40.27%
3,625,014 $75.7 Million
Q1 2024

May 10, 2024
SELL
$7.77 - $15.66 $107,202 - $216,061
-13,797 Reduced 0.53%
2,584,300 $38 Million
Q4 2023

Feb 14, 2024
SELL
$4.25 - $10.71 $496,179 - $1.25 Million
-116,748 Reduced 4.3%
2,598,097 $26.8 Million
Q3 2023

Nov 14, 2023
BUY
$7.86 - $10.08 $179,239 - $229,864
22,804 Added 0.85%
2,714,845 $21.3 Million
Q2 2023

Aug 14, 2023
BUY
$8.7 - $13.28 $596,698 - $910,822
68,586 Added 2.61%
2,692,041 $26.9 Million
Q1 2023

May 15, 2023
BUY
$8.56 - $13.26 $3.6 Million - $5.58 Million
420,850 Added 19.11%
2,623,455 $23.3 Million
Q4 2022

Feb 10, 2023
BUY
$9.86 - $14.59 $411,546 - $608,972
41,739 Added 1.93%
2,202,605 $24.2 Million
Q3 2022

Nov 14, 2022
BUY
$12.33 - $19.81 $608,732 - $978,019
49,370 Added 2.34%
2,160,866 $28.2 Million
Q2 2022

Aug 12, 2022
BUY
$7.88 - $14.82 $657,452 - $1.24 Million
83,433 Added 4.11%
2,111,496 $26.8 Million
Q1 2022

May 13, 2022
BUY
$12.94 - $29.65 $485,237 - $1.11 Million
37,499 Added 1.88%
2,028,063 $28.4 Million
Q4 2021

Feb 14, 2022
BUY
$26.43 - $34.5 $333,361 - $435,148
12,613 Added 0.64%
1,990,564 $57.6 Million
Q3 2021

Nov 12, 2021
BUY
$22.71 - $36.69 $11.6 Million - $18.8 Million
511,814 Added 34.91%
1,977,951 $59.3 Million
Q2 2021

Aug 13, 2021
BUY
$24.21 - $35.89 $35.5 Million - $52.6 Million
1,466,137 New
1,466,137 $38.9 Million

Others Institutions Holding NRIX

# of Institutions
181
Shares Held
68.1M
Call Options Held
78K
Put Options Held
53.8K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $1.01B
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email